Extracellular nucleotide signaling in solid organ transplantation

Area of Science:

• Immunology
• Transplantation Biology
• Cell Signaling

Background:

• Extracellular purine nucleotides, including adenosine triphosphate (ATP) and adenosine, play critical roles in modulating posttransplantation outcomes.
• Ischemia-reperfusion injury is a major challenge in transplantation, significantly affecting graft viability and long-term success.
• Purinergic signaling, involving P1 and P2 receptors, influences inflammation and tissue damage.

Purpose of the Study:

• To review the current understanding of extracellular nucleotide signaling in transplantation.
• To focus on the sources and functions of extracellular ATP in the context of transplantation.
• To discuss the interplay between ischemia-reperfusion, purinergic signaling, and graft preservation.

Main Methods:

• Literature review of studies on purinergic signaling in transplantation.
• Analysis of the roles of extracellular ATP and adenosine in posttransplant inflammation and rejection.
• Examination of novel therapeutic strategies targeting purinergic signaling.

Main Results:

• Activation of P2 purinergic receptors by released ATP promotes tissue injury and inflammation.
• Activation of P1 receptors for adenosine attenuates inflammation and limits ischemia-induced damage.
• Extracellular nucleotides are key factors in both promoting and suppressing posttransplant inflammation and allograft rejection.

Conclusions:

• Purinergic signaling critically influences transplant outcomes and ischemia-reperfusion injury.
• Targeting purinergic pathways offers potential for enhancing graft viability and reducing complications.
• Further research into therapeutic approaches modulating purinergic signaling is warranted to improve transplant success.